Insulin absorption at subcutaneous tissue

Insulin absorption at subcutaneous tissue refers to the movement of exogenously administered insulin from the subcutaneous compartment (primarily composed of adipose and connective tissue) into the bloodstream[1][5][7]. This process is central to the delivery of insulin therapy in diabetes and is influenced by numerous physiological and technical factors: local tissue vascularity, adipose tissue thickness, injection depth, presence of inflammatory or fibrotic tissue from prior injections, drug formulation, and temperature[1][3][5][6]. Variability in subcutaneous absorption contributes significantly to inconsistencies in glycemic control, posing risks for both hypoglycemic episodes and hyperglycemia. Devices and injection techniques (e.g., vascularizing microchambers) are being explored to improve the speed and consistency of this absorption[1]. Note: This entry describes a pharmacokinetic process, not a distinct biological target. If your intention was to identify a specific molecular mediator or transporter involved in this process (such as a specific tissue property or protein facilitating insulin uptake), please clarify.

Other names

Insulin subcutaneous absorptionSubcutaneous insulin uptakeSC insulin pharmacokinetics

Not applicable (refers to a process, not a molecular mechanism of drug action)